626 related articles for article (PubMed ID: 9412549)
1. Effect of regular inhaled albuterol on allergen-induced late responses and sputum eosinophils in asthmatic subjects.
Gauvreau GM; Jordana M; Watson RM; Cockroft DW; O'Byrne PM
Am J Respir Crit Care Med; 1997 Dec; 156(6):1738-45. PubMed ID: 9412549
[TBL] [Abstract][Full Text] [Related]
2. Effect of salmeterol compared with beclomethasone on allergen-induced asthmatic and inflammatory responses.
Pizzichini MM; Kidney JC; Wong BJ; Morris MM; Efthimiadis A; Dolovich J; Hargreave FE
Eur Respir J; 1996 Mar; 9(3):449-55. PubMed ID: 8730003
[TBL] [Abstract][Full Text] [Related]
3. Potential masking effects of salmeterol on airway inflammation in asthma.
Mcivor RA; Pizzichini E; Turner MO; Hussack P; Hargreave FE; Sears MR
Am J Respir Crit Care Med; 1998 Sep; 158(3):924-30. PubMed ID: 9731027
[TBL] [Abstract][Full Text] [Related]
4. The inhibitory effect of nebulized albuterol on the early and late asthmatic reactions and increase in airway responsiveness provoked by inhaled allergen in asthma.
Twentyman OP; Finnerty JP; Holgate ST
Am Rev Respir Dis; 1991 Oct; 144(4):782-7. PubMed ID: 1928949
[TBL] [Abstract][Full Text] [Related]
5. Mast cell tryptase release and asthmatic responses to allergen increase with regular use of salbutamol.
Swystun VA; Gordon JR; Davis EB; Zhang X; Cockcroft DW
J Allergy Clin Immunol; 2000 Jul; 106(1 Pt 1):57-64. PubMed ID: 10887306
[TBL] [Abstract][Full Text] [Related]
6. Effect of a single dose of salmeterol on the increase in airway eosinophils induced by allergen challenge in asthmatic subjects.
Dente FL; Bancalari L; Bacci E; Bartoli ML; Carnevali S; Cianchetti S; Di Franco A; Giannini D; Vagaggini B; Testi R; Paggiaro PL
Thorax; 1999 Jul; 54(7):622-4. PubMed ID: 10377209
[TBL] [Abstract][Full Text] [Related]
7. A dose-dependent effect of the novel inhaled corticosteroid ciclesonide on airway responsiveness to adenosine-5'-monophosphate in asthmatic patients.
Taylor DA; Jensen MW; Kanabar V; Engelstätter R; Steinijans VW; Barnes PJ; O'Connor BJ
Am J Respir Crit Care Med; 1999 Jul; 160(1):237-43. PubMed ID: 10390406
[TBL] [Abstract][Full Text] [Related]
8. One week treatment with salmeterol does not prevent early and late asthmatic responses and sputum eosinophilia induced by allergen challenge in asthmatics.
Dente FL; Bacci E; Bartoli ML; Cianchetti S; Di Franco A; Giannini D; Taccola M; Vagaggini B; Paggiaro PL
Pulm Pharmacol Ther; 2004; 17(3):147-53. PubMed ID: 15123224
[TBL] [Abstract][Full Text] [Related]
9. Effect of IVL745, a VLA-4 antagonist, on allergen-induced bronchoconstriction in patients with asthma.
Norris V; Choong L; Tran D; Corden Z; Boyce M; Arshad H; Holgate S; O'Connor B; Millet S; Miller B; Rohatagi S; Kirkesseli S
J Allergy Clin Immunol; 2005 Oct; 116(4):761-7. PubMed ID: 16210048
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of fluticasone and montelukast on allergen-induced asthma.
Palmqvist M; Bruce C; Sjöstrand M; Arvidsson P; Lötvall J
Allergy; 2005 Jan; 60(1):65-70. PubMed ID: 15575933
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of fluticasone on allergen-induced airway responses and sputum inflammatory markers.
Parameswaran K; Inman MD; Watson RM; Morris MM; Efthimiadis A; Ventresca PG; Lam R; O'Byrne PM; Hargreave FE
Can Respir J; 2000; 7(4):313-9. PubMed ID: 10980457
[TBL] [Abstract][Full Text] [Related]
12. The effect of montelukast (MK-0476), a cysteinyl leukotriene receptor antagonist, on allergen-induced airway responses and sputum cell counts in asthma.
Diamant Z; Grootendorst DC; Veselic-Charvat M; Timmers MC; De Smet M; Leff JA; Seidenberg BC; Zwinderman AH; Peszek I; Sterk PJ
Clin Exp Allergy; 1999 Jan; 29(1):42-51. PubMed ID: 10051701
[TBL] [Abstract][Full Text] [Related]
13. Comparison between allergen-induced and exercise-induced asthma with respect to the late asthmatic response, airway responsiveness, and Creola bodies in sputum.
Tateishi K; Motojima S; Kushima A; Fukuda T; Makino S
Ann Allergy Asthma Immunol; 1996 Sep; 77(3):229-37. PubMed ID: 8814050
[TBL] [Abstract][Full Text] [Related]
14. Effect of inhaled leukotriene D4 on airway eosinophilia and airway hyperresponsiveness in asthmatic subjects.
Mulder A; Gauvreau GM; Watson RM; O'byrne PM
Am J Respir Crit Care Med; 1999 May; 159(5 Pt 1):1562-7. PubMed ID: 10228127
[TBL] [Abstract][Full Text] [Related]
15. Protective effects of inhaled PGE2 on allergen-induced airway responses and airway inflammation.
Gauvreau GM; Watson RM; O'Byrne PM
Am J Respir Crit Care Med; 1999 Jan; 159(1):31-6. PubMed ID: 9872814
[TBL] [Abstract][Full Text] [Related]
16. The effect of regular inhaled albuterol on exercise-induced bronchoconstriction.
Inman MD; O'Byrne PM
Am J Respir Crit Care Med; 1996 Jan; 153(1):65-9. PubMed ID: 8542164
[TBL] [Abstract][Full Text] [Related]
17. Interaction of inhaled beta 2 agonist and inhaled corticosteroid on airway responsiveness to allergen and methacholine.
Cockcroft DW; Swystun VA; Bhagat R
Am J Respir Crit Care Med; 1995 Nov; 152(5 Pt 1):1485-9. PubMed ID: 7582281
[TBL] [Abstract][Full Text] [Related]
18. Effect of inhaled interleukin-5 on airway hyperreactivity and eosinophilia in asthmatics.
Shi HZ; Xiao CQ; Zhong D; Qin SM; Liu Y; Liang GR; Xu H; Chen YQ; Long XM; Xie ZF
Am J Respir Crit Care Med; 1998 Jan; 157(1):204-9. PubMed ID: 9445301
[TBL] [Abstract][Full Text] [Related]
19. Dose-dependent effects of inhaled mometasone furoate on airway function and inflammation after allergen inhalation challenge.
Inman MD; Watson RM; Rerecich T; Gauvreau GM; Lutsky BN; Stryszak P; O'Byrne PM
Am J Respir Crit Care Med; 2001 Aug; 164(4):569-74. PubMed ID: 11520717
[TBL] [Abstract][Full Text] [Related]
20. An inhaled glucocorticoid does not prevent tolerance to the bronchoprotective effect of a long-acting inhaled beta 2-agonist.
Yates DH; Kharitonov SA; Barnes PJ
Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1603-7. PubMed ID: 8970342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
